Skip to main content

Table 1 Participant demographic and clinical characteristics

From: Characteristics of footwear worn by people with systemic lupus erythematosus: a comparison with age- and sex-matched healthy controls: a pilot study

 

SLE

Control

N

22

20

Sex, female, n (%)

20 (91%)

18 (90%)

Age, years

51 (15)

51 (12)

Ethnicity, n (%)

 European

13 (59%)

17 (85%)

 Māori

2 (9%)

1 (5%)

 Pacific

1 (5%)

0 (0%)

 Asian

6 (27%)

1 (5%)

 Other

0 (0%)

1 (5)

Body mass index, kg/m2

27.1 (7.0)

26.3 (5.3)

SLE disease duration, years

14.3 (10.3)

-

SLEDAI-2K

12.0 (8.2)

-

Medications, n (%)

 Hydroxychloroquine

12 (55%)

 

 Immunosuppressive

10 (42%)

 

 NSAID

10 (45%)

 

 Prednisone

11 (50%)

 

Comorbidities and complications of disease, n (%)

 Raynaud’s syndrome

9 (41%)

 

 Lupus nephritis

3 (14%)

 

 Hypertension

3 (14%)

 

 Cardiovascular disease

2 (9%)

 

 Dyslipidaemia

2 (9%)

 

 Sjögren syndrome

2 (9%)

 

 Osteoporosis

2 (9%)

 

 Fibromyalgia

1 (5%)

 

 Depression

2 (9%)

 
  1. Values are presented as mean (SD) unless otherwise indicated. SLEDAI-2K: systematic lupus erythematosus disease activity index – 2000; NSAID: non-steroidal anti-inflammatory drug